Concepedia

Shufang Bin

SB

4

Publications

164

Citations

4

H-Index

2018

Active since

Affiliations

Wenzhou Medical University(Current)

Capital Medical University

First Affiliated Hospital of Wenzhou Medical University

Shufang Bin is an author at Wenzhou Medical University specializing in cell biology, cancer therapeutics, and tumor immunity.

Top concepts

Publications per year

2018–2020

4

Publications

4

The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2 in vitro and in Immune Competent Mice

Panyuan Li, Lingcong Yang, Tong Li et al. · Frontiers in Oncology · 2020 · 52 citations · Full text

The efficacy of third generation anti‑HER2 chimeric antigen receptor T�cells in combination with PD1 blockade against malignant glioblastoma cells

Luxi Shen, Hongzhi Li, Shufang Bin et al. · Oncology Reports · 2019 · 51 citations · Full text

Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li, Weihua Yuan, Shufang Bin et al. · PubMed · 2020 · 36 citations · Full text

, , +15

Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti‐Her2 chimeric antigen receptor gene

Weihua Yuan, Jie Chen, Ying Cao et al. · The Journal of Gene Medicine · 2018 · 25 citations

Rows per page

1–4 of 4